We have developed a number of resources, including cell lines, PDXs, epigenomic datasets, and a genetically engineered mouse model, that we employed to answer fundamental questions and are well suited for future investigations to explore further details about PAX2’s function as a tumor suppressor or its interactions with PI3K/PTEN and other cancer-causing pathways. This evidence concerns the gene PTEN and neoplasm.